Dixie Brands Inc. (CNSX:DIXI.U) acquired 25% stake in Therabis, LLC from Rose Capital Fund I, LP backed by Bold Rose Capital Partners for $8.3 million on January 2, 2019. As part of the consideration, Dixie Brands Inc paid $3.9 million of initial closing payment, $3.5 million of deferred closing payment and $0.88 million for the promissory notes of which principal totals $0.8 million and interest totals $0.1 million. Dixie Brands Inc. (CNSX:DIXI.U) acquired 25% stake in Therabis, LLC from Rose Capital Fund I, LP backed by Bold Rose Capital Partners on January 2, 2019